Effect of Maternal BMI on Measurement of Cervical Length
Effect of Maternal BMI on Accuracy of Measurement of Cervical Length During the 3rd Trimester of Pregnancy
1 other identifier
observational
300
1 country
1
Brief Summary
All consecutive pregnant patients in 2nd or 3rd trimester will be asked to participate. Cervical length will be assessed in all patients, once abdominally and then vaginally (that would serve as golden standard). Correlation would be assessed between accuracy of measurement to BMI
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2013
CompletedFirst Posted
Study publicly available on registry
June 20, 2013
CompletedStudy Start
First participant enrolled
July 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedJune 20, 2013
June 1, 2013
1 year
June 11, 2013
June 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of cervical length according to BMI
the golden standard for cervical length measurement is vaginal scan. Our outcome measure will be the accuracy of cervical length measurement - measured abdominally, according to BMI. I other words - was there a difference between measurement by vaginal probe and abdominal probe and whether this difference correlates with BMI
1 year
Secondary Outcomes (1)
Gestational age at delivery according to cervical length
1 year
Eligibility Criteria
All pregnant women in 2nd or 3rd trimester who attend routine ultrasound exam
You may qualify if:
- All pregnant women in 2nd or 3rd trimester who attend routine ultrasound exam
You may not qualify if:
- Known shore cervix
- PPROM
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hillel Yaffe Medical Center
Hadera, Israel
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2013
First Posted
June 20, 2013
Study Start
July 1, 2013
Primary Completion
July 1, 2014
Study Completion
July 1, 2015
Last Updated
June 20, 2013
Record last verified: 2013-06